Literature DB >> 24924298

Expression and regulation of triggering receptor expressed on myeloid cells 1 in periodontal diseases.

M Willi1, G N Belibasakis, N Bostanci.   

Abstract

Periodontitis is an inflammatory infectious disease that destroys the tooth-supporting tissues. It is caused by multi-species subgingival biofilms that colonize the tooth surface. Porphyromonas gingivalis, Treponema denticola and Tannerella forsythia (i.e. 'red complex' bacteria) are characteristic subgingival biofilm species. The triggering receptor expressed on myeloid cells 1 (TREM-1) is a cell surface receptor of the immunoglobulin superfamily, with a role in the amplification of proinflammatory cytokine production during infection. This study aimed to investigate TREM-1 mRNA expression in gingival tissues from patients with chronic periodontitis, generalized aggressive periodontitis and healthy subjects and its correlation with the levels of periodontal pathogens in the tissue. A further aim was to investigate the regulation of TREM-1 in human monocytic cells (MM6) challenged with an in-vitro subgingival biofilm model. Gingival tissue TREM-1 expression was increased in both chronic and aggressive periodontitis, compared to health, and correlated with the levels of the 'red complex' species in the tissue. No significant differences were detected between the two forms of periodontitis. Biofilm-challenged MM6 cells exhibited higher TREM-1 expression and secretion compared to controls, with partial involvement of the 'red complex'. Engagement or inhibition of TREM-1 affected the capacity of the biofilms to stimulate interleukin (IL)-1β, but not IL-8, secretion by the cells. In conclusion, this study reveals that TREM-1 tissue expression is enhanced in periodontal disease, and correlates with the level of periodontal pathogens. It also provides a mechanistic insight into the regulation of TREM-1 expression and the associated IL-1β production in biofilm-challenged monocytes.
© 2014 British Society for Immunology.

Entities:  

Keywords:  TREM-1; gingival tissue; inflammation; monocytes; periodontal pathogens; periodontitis

Mesh:

Substances:

Year:  2014        PMID: 24924298      PMCID: PMC4360207          DOI: 10.1111/cei.12397

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  31 in total

1.  Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes.

Authors:  A Bouchon; J Dietrich; M Colonna
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

Review 2.  Aggregatibacter (Actinobacillus) actinomycetemcomitans: a triple A* periodontopathogen?

Authors:  Brian Henderson; John M Ward; Derren Ready
Journal:  Periodontol 2000       Date:  2010-10       Impact factor: 7.589

3.  Soluble triggering receptor expressed on myeloid cells 1 (sTREM-1) in gingival crevicular fluid: association with clinical and microbiologic parameters.

Authors:  Georgios N Belibasakis; Veli-Özgen Öztürk; Gulnur Emingil; Nagihan Bostanci
Journal:  J Periodontol       Date:  2013-05-09       Impact factor: 6.993

4.  Validation of a quantitative real-time PCR assay and comparison with fluorescence microscopy and selective agar plate counting for species-specific quantification of an in vitro subgingival biofilm model.

Authors:  T W Ammann; N Bostanci; G N Belibasakis; T Thurnheer
Journal:  J Periodontal Res       Date:  2012-12-30       Impact factor: 4.419

5.  Doxycycline inhibits TREM-1 induction by Porphyromonas gingivalis.

Authors:  Nagihan Bostanci; Georgios N Belibasakis
Journal:  FEMS Immunol Med Microbiol       Date:  2012-05-21

6.  Down-regulation of NLRP3 inflammasome in gingival fibroblasts by subgingival biofilms: involvement of Porphyromonas gingivalis.

Authors:  Georgios N Belibasakis; Bernhard Guggenheim; Nagihan Bostanci
Journal:  Innate Immun       Date:  2012-04-20       Impact factor: 2.680

7.  The RANKL-OPG system is differentially regulated by supragingival and subgingival biofilm supernatants.

Authors:  Georgios N Belibasakis; Andre Meier; Bernhard Guggenheim; Nagihan Bostanci
Journal:  Cytokine       Date:  2011-04-06       Impact factor: 3.861

8.  Induction of prostaglandin E(2) and interleukin-6 in gingival fibroblasts by oral biofilms.

Authors:  Georgios N Belibasakis; Bernhard Guggenheim
Journal:  FEMS Immunol Med Microbiol       Date:  2011-10-04

9.  Elevated oral and systemic levels of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) in periodontitis.

Authors:  N Bostanci; V Ö Oztürk; G Emingil; G N Belibasakis
Journal:  J Dent Res       Date:  2012-12-14       Impact factor: 6.116

10.  Porphyromonas gingivalis regulates TREM-1 in human polymorphonuclear neutrophils via its gingipains.

Authors:  Nagihan Bostanci; Thomas Thurnheer; Joseph Aduse-Opoku; Michael A Curtis; Annelies S Zinkernagel; Georgios N Belibasakis
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

View more
  12 in total

1.  Silencing Triggering Receptors Expressed on Myeloid Cells-1 Impaired the Inflammatory Response to Oxidized Low-Density Lipoprotein in Macrophages.

Authors:  Houxuan Li; Feifei Hong; Shengbo Pan; Lang Lei; Fuhua Yan
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

2.  Soluble Epoxide Hydrolase Inhibitor Suppresses the Expression of Triggering Receptor Expressed on Myeloid Cells-1 by Inhibiting NF-kB Activation in Murine Macrophage.

Authors:  Liang Dong; Yong Zhou; Zhao-Qiong Zhu; Tian Liu; Jia-Xi Duan; Jun Zhang; Ping Li; Bruce D Hammcok; Cha-Xiang Guan
Journal:  Inflammation       Date:  2017-02       Impact factor: 4.092

Review 3.  Triggering receptor expressed on myeloid cells in the pathogenesis of periodontitis: potential novel treatment strategies.

Authors:  Courtney P Rudick; Takanari Miyamoto; Melissa S Lang; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2017-10-20       Impact factor: 4.473

4.  Quantification by qPCR of Pathobionts in Chronic Periodontitis: Development of Predictive Models of Disease Severity at Site-Specific Level.

Authors:  Inmaculada Tomás; Alba Regueira-Iglesias; Maria López; Nora Arias-Bujanda; Lourdes Novoa; Carlos Balsa-Castro; Maria Tomás
Journal:  Front Microbiol       Date:  2017-08-09       Impact factor: 5.640

5.  Incorporation of staphylococci into titanium-grown biofilms: an in vitro "submucosal" biofilm model for peri-implantitis.

Authors:  Thomas Thurnheer; Georgios N Belibasakis
Journal:  Clin Oral Implants Res       Date:  2015-10-13       Impact factor: 5.977

Review 6.  Virulence and Pathogenicity Properties of Aggregatibacter actinomycetemcomitans.

Authors:  Georgios N Belibasakis; Terhi Maula; Kai Bao; Mark Lindholm; Nagihan Bostanci; Jan Oscarsson; Riikka Ihalin; Anders Johansson
Journal:  Pathogens       Date:  2019-11-06

7.  Salivary Total Protease Activity Based on a Broad-Spectrum Fluorescence Resonance Energy Transfer Approach to Monitor Induction and Resolution of Gingival Inflammation.

Authors:  Floris J Bikker; Gustavo G Nascimento; Kamran Nazmi; Angelika Silbereisen; Georgios N Belibasakis; Wendy E Kaman; Rodrigo Lopez; Nagihan Bostanci
Journal:  Mol Diagn Ther       Date:  2019-10       Impact factor: 4.074

8.  TREM-1 Is Upregulated in Experimental Periodontitis, and Its Blockade Inhibits IL-17A and RANKL Expression and Suppresses Bone loss.

Authors:  Nagihan Bostanci; Toshiharu Abe; Georgios N Belibasakis; George Hajishengallis
Journal:  J Clin Med       Date:  2019-10-01       Impact factor: 4.241

9.  Salivary proteotypes of gingivitis tolerance and resilience.

Authors:  Nagihan Bostanci; Angelika Silbereisen; Kai Bao; Jonas Grossmann; Paolo Nanni; Claudia Fernandez; Gustavo G Nascimento; Georgios N Belibasakis; Rodrigo Lopez
Journal:  J Clin Periodontol       Date:  2020-09-16       Impact factor: 8.728

10.  Severe Periodontitis and Biomarkers of Bacterial Burden. Results From a Case-Control and Intervention Clinical Trial.

Authors:  Yago Leira; Dimitrios Fragkiskos; Marco Orlandi; Jeanie Suvan; Luigi Nibali; Maurizio S Tonetti; Georgios N Belibasakis; Nagihan Bostanci; Francesco D'Aiuto
Journal:  Front Oral Health       Date:  2021-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.